Bit Digital, Inc. (Nasdaq: BTBT) (“Bit Digital” or the “Company”) today announced its monthly Ethereum (“ETH”) treasury and staking metrics for the month of October 2025: https://mma.prnewswire.com/media/1936804/Bit_Digital_Logo.jpg Key Highlights for October 2025 — As of October 31, 2025, the Company held approximately 153,546.9[1] ETH. — Based on a closing ETH price of $3,845.79, as of […]
Coreline Softwill introduce its groundbreaking chest AI platform AVIEW 2.0 at RSNA 2025 (November 30-December 4, Chicago), demonstrating how unified AI automation is fundamentally transforming radiology workflows and elevating diagnostic precision across pulmonary, cardiac, and airway pathologies. https://mma.prnewswire.com/media/2521520/CorelineSoft_Logo.jpg AVIEW 2.0 represents a paradigm shift from task-specific tools to an integrated diagnostic ecosystem. The platform seamlessly
In appreciation of U.S. military veterans and active-duty service members, Autobell Car Wash will offer them a free Ride-Thru Exterior wash, or an equivalent credit toward another wash option, onTuesday, November 11, 2025,at allAutobell locationsinNorth Carolina, South Carolina, Virginia,Maryland, and Delaware. No coupon, barcode, or ID is required. In the event of rain on the
MAX Power Begins Historic Drilling of Canada's First-Ever Natural Hydrogen Well GlobeNewswire November 07, 2025 The Lawson Target Exhibits All Five Key Elements for a Potential Natural Hydrogen Accumulation Including Source Rocks, Migration Pathways, Reservoirs, Seals and Traps, Along With a Defined Four-Way Structural Closure MAX Power Saskatchewan Natural Hydrogen Documentary Videohttps://www.maxpowermining.com/NaturalHydrogen-NewEra/ SASKATOON, Saskatchewan, Nov.
Dupixent(R) (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA Priority Review GlobeNewswire November 07, 2025 Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal congestion and nasal polyps in
Biofrontera Inc. announces sale of license to Xepi(R) Antibiotic Cream to Pelthos Therapeutics Inc. for up to $10M GlobeNewswire November 07, 2025 Proceeds of up to $10 million, consisting of $3 million at closing, $1 million upon availability of commercial product, and up to $6 million in sales-related milestone payments. Transaction further bolsters our cash
Bioprocess Containers Market to Soar from USD 3.12 Billion in 2024 to USD 31.91 Billion by 2034, Driven by the Shift Toward Single-Use Bioprocessing Systems The global bioprocess containers market size is calculated at USD 3.93 billion in 2025 and is expected to reach around USD 31.91 billion by 2034, growing at a CAGR of
Vaxart to Host Upcoming Conference Calls GlobeNewswire November 07, 2025 Third quarter 2025 results conference call to be held on November 13 at 4:30 p.m. ET Stockholder fireside chat to be held on November 18 at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”) today
Pelthos Therapeutics Acquires Xepi(R) (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing GlobeNewswire November 07, 2025 Acquisition adds complementary dermatology product to the Pelthos portfolio anchored by ZELSUVMI(TM) Xepi is a novel FDA-approved topical treatment for impetigo that addresses a critical unmet need in antibiotic-resistant skin infections caused by staph and strep
Black Friday Starts Early at Curacao: Three Weeks of Massive Savings You Can't Miss Shoppers Get a Head Start on Holiday Savings with Three Weeks of Massive Early Black Friday Deals and Exclusive Curacao Club Discounts GlobeNewswire November 07, 2025 LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) — Curacao, one of the largest Hispanic-focused retailers